Tennis superstar Serena Williams is facing backlash after publicly promoting GLP-1 weight loss medications, including popular drugs like Ozempic. Actress and activist Jameela Jamil didn’t hold back, warning the public about the risks of these so-called miracle medications.
Jamil took to social media in a lengthy rant, cautioning fans that these medications “come at a price” — one that she says many aren’t being told about.
The Risks Jameela Highlights
According to Jameela, GLP-1 medications carry a long list of serious side effects, including:
- Gastric system paralysis
- Pancreatitis
- Cancer
- Hair loss
- Osteoporosis
- Severe malnutrition
- Muscle mass loss
- Depression
- Thyroid issues
- Blindness
- Metabolic complications
She also warns that some individuals rapidly regain weight if they stop taking the drugs, making them potentially dangerous for those without medical supervision.
Serena’s Media Push
Serena Williams has been in the spotlight this week leading up to the 2025 US Open Tennis Championship, promoting her own use of GLP-1 medications in partnership with Ro, a healthcare company where her husband holds a significant board position.
In media appearances, Serena claimed she lost 31 pounds with the help of GLP-1s — a statistic that has sparked both intrigue and controversy.
Jameela Questions Celebrity Influence
Jameela’s criticism goes beyond just the drugs themselves. She points out the ethical concern of celebrities promoting high-risk medications when they have access to top-tier doctors and medical resources unavailable to the general public.
“It’s uncomfortable seeing celebs with access to the best doctors promote these medications as a ‘miracle’ when the risks are real,” she said.
Her comments have ignited conversation online, with fans and critics debating the responsibility of public figures in influencing health decisions.
Public Reaction: Support and Skepticism
Social media responses have been split:
- Supporters of Jameela applaud her for raising awareness of health risks and urging caution.
- Fans of Serena argue that she is simply sharing her personal experience and helping others who struggle with weight management.
The debate highlights the growing tension between celebrity endorsements and real-world medical guidance.
The Broader GLP-1 Controversy
GLP-1 medications have surged in popularity recently, hailed by some as revolutionary for weight loss but criticized by experts for potential side effects. Celebrities like Serena Williams are bringing these drugs into mainstream conversation, but experts warn that individual results vary and the drugs are not without risks.
As Jameela points out, celebrities must weigh their influence carefully, especially when promoting medications that can have serious long-term consequences.
What’s Next for Serena Williams?
With the US Open around the corner, Serena’s promotion of GLP-1s will likely continue to attract media attention. Meanwhile, Jameela’s critique ensures that public health conversations about the safety and ethics of these drugs remain at the forefront.
What do you think — is Serena Williams responsibly sharing her weight loss journey, or should celebs avoid promoting high-risk medications? Drop your thoughts below!
